Company / SG&A Expense
Cytosorbents Corp SG&A Expense History
FY2011-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$20.9M
FY2018
5-year range
$5.6M / $20.9M
FY2014-FY2018
Trend
+40.0%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $6M to $21M over the past 2 years.
Based on SEC 10-K filings.
$21M in FY2018 with a 5-year CAGR of +72.8%.
Increased from $6M to $21M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +44.5%
- 5-Year CAGR
- +72.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +72.8%, indicating consistent growth.
- In FY2018, sg&a expense increased 40.0% year-over-year.
- Lowest sg&a expense in the period was in FY2011.
Company context
Key Data Points
- Altman Z-Score -4.61 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2018 | $20.9M | +40.0% |
| FY2017 | $14.9M | +168.6% |
| FY2016 | $5.6M | -19.8% |
| FY2015 | $6.9M | +24.7% |
| FY2014 | $5.6M | +309.9% |
| FY2013 | $1.4M | +0.0% |
| FY2012 | $1.4M | +10.1% |
| FY2011 | $1.2M | - |
As of FY2018 · SEC 10-K · Updated Jun 24, 2026